Zdrowie i gospodarka · 03/09/2024
FDA Revokes Authorization for COVID-19 Diagnostic Test
The FDA revoked the Emergency Use Authorization for Roche Molecular Systems' cobas SARS-CoV-2 & Influenza A/B test due to a request from the Authorization holder, citing the Federal Food, Drug, and Cosmetic Act.
Source: Federal Register — Food and Drug AdministrationOpen original release →
Related company profile: RocheOpen profile →